Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prospective Assessment of Lymphedema Incidence and Lymphedema-associated Symptoms Following Lymph Node Surgery for Melanoma

Identifieur interne : 003258 ( Main/Exploration ); précédent : 003257; suivant : 003259

Prospective Assessment of Lymphedema Incidence and Lymphedema-associated Symptoms Following Lymph Node Surgery for Melanoma

Auteurs : John R. Hyngstrom [États-Unis] ; Yi-Ju Chiang [États-Unis] ; Kate D. Cromwell [États-Unis] ; Merrick I. Ross [États-Unis] ; Yan Xing [États-Unis] ; Kristi S. Mungovan [États-Unis] ; Jeffrey E. Lee ; Jeffrey E. Gershenwald [États-Unis] ; Richard E. Royal [États-Unis] ; Anthony Lucci [États-Unis] ; Jane M. Armer [États-Unis] ; Janice N. Cormier [États-Unis]

Source :

RBID : PMC:3881422

Descripteurs français

English descriptors

Abstract

Aims

We sought to prospectively assess limb volume change (LVC) and associated symptoms in patients with melanoma undergoing sentinel lymph node (SLN) biopsy and/or therapeutic lymph node dissection (TLND).

Methods

Limb volume was measured pre-operatively and post-operatively at 6 and 12 months using a perometer (JUZO 1000M). LVC calculated and used to define 3 groups: <5%, 5-10%, and >10%. A 19-item lymphedema symptom questionnaire was administered at baseline, 6-month and 12-months.

Results

One hundred eighty-two patients were enrolled. Twelve months after axillary surgery, 9% had LVC 5-10%, and 13% had LVC >10%. Twelve months after inguino-femoral surgery, 10% had LVC 5-10%, and 13% had LVC >10%. There was a significant 7- to 9-fold increase in symptoms for patients with LVC greater than >10% compared to those with LVC <5% (P<.05). By multivariate analysis, TLND versus SLN biopsy (odds ratio [OR] = 3.18 P<0.01) and borderline significance for lower-versus upper-extremity procedures (OR=1.72; P=0.07) were associated with LVC >5%.

Conclusion

LVC greater than 5% is common at 12 months following nodal surgery for melanoma and is associated with symptoms. Informed consent for melanoma patients undergoing lymph node surgery should include a discussion of the risks of post-operative lymphedema.


Url:
DOI: 10.1097/CMR.0b013e3283632c83
PubMed: 23752305
PubMed Central: 3881422


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Prospective Assessment of Lymphedema Incidence and Lymphedema-associated Symptoms Following Lymph Node Surgery for Melanoma</title>
<author>
<name sortKey="Hyngstrom, John R" sort="Hyngstrom, John R" uniqKey="Hyngstrom J" first="John R." last="Hyngstrom">John R. Hyngstrom</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chiang, Yi Ju" sort="Chiang, Yi Ju" uniqKey="Chiang Y" first="Yi-Ju" last="Chiang">Yi-Ju Chiang</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Cromwell, Kate D" sort="Cromwell, Kate D" uniqKey="Cromwell K" first="Kate D." last="Cromwell">Kate D. Cromwell</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I." last="Ross">Merrick I. Ross</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Xing, Yan" sort="Xing, Yan" uniqKey="Xing Y" first="Yan" last="Xing">Yan Xing</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mungovan, Kristi S" sort="Mungovan, Kristi S" uniqKey="Mungovan K" first="Kristi S." last="Mungovan">Kristi S. Mungovan</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lee, Jeffrey E" sort="Lee, Jeffrey E" uniqKey="Lee J" first="Jeffrey E." last="Lee">Jeffrey E. Lee</name>
</author>
<author>
<name sortKey="Gershenwald, Jeffrey E" sort="Gershenwald, Jeffrey E" uniqKey="Gershenwald J" first="Jeffrey E." last="Gershenwald">Jeffrey E. Gershenwald</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Royal, Richard E" sort="Royal, Richard E" uniqKey="Royal R" first="Richard E." last="Royal">Richard E. Royal</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lucci, Anthony" sort="Lucci, Anthony" uniqKey="Lucci A" first="Anthony" last="Lucci">Anthony Lucci</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M." last="Armer">Jane M. Armer</name>
<affiliation wicri:level="2">
<nlm:aff id="A2">Sinclair School of Nursing/Ellis Fischel Cancer Center, Sinclair School of Nursing, University of Missouri, Columbia, MO</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Sinclair School of Nursing/Ellis Fischel Cancer Center, Sinclair School of Nursing, University of Missouri, Columbia</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N." last="Cormier">Janice N. Cormier</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">23752305</idno>
<idno type="pmc">3881422</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881422</idno>
<idno type="RBID">PMC:3881422</idno>
<idno type="doi">10.1097/CMR.0b013e3283632c83</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">003899</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003899</idno>
<idno type="wicri:Area/Pmc/Curation">003898</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003898</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002040</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002040</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">001A90</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A90</idno>
<idno type="wicri:Area/PubMed/Curation">001A90</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A90</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A90</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A90</idno>
<idno type="wicri:Area/Ncbi/Merge">005A12</idno>
<idno type="wicri:Area/Ncbi/Curation">005A12</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005A12</idno>
<idno type="wicri:doubleKey">0960-8931:2013:Hyngstrom J:prospective:assessment:of</idno>
<idno type="wicri:Area/Main/Merge">003263</idno>
<idno type="wicri:Area/Main/Curation">003258</idno>
<idno type="wicri:Area/Main/Exploration">003258</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Prospective Assessment of Lymphedema Incidence and Lymphedema-associated Symptoms Following Lymph Node Surgery for Melanoma</title>
<author>
<name sortKey="Hyngstrom, John R" sort="Hyngstrom, John R" uniqKey="Hyngstrom J" first="John R." last="Hyngstrom">John R. Hyngstrom</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chiang, Yi Ju" sort="Chiang, Yi Ju" uniqKey="Chiang Y" first="Yi-Ju" last="Chiang">Yi-Ju Chiang</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Cromwell, Kate D" sort="Cromwell, Kate D" uniqKey="Cromwell K" first="Kate D." last="Cromwell">Kate D. Cromwell</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I." last="Ross">Merrick I. Ross</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Xing, Yan" sort="Xing, Yan" uniqKey="Xing Y" first="Yan" last="Xing">Yan Xing</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mungovan, Kristi S" sort="Mungovan, Kristi S" uniqKey="Mungovan K" first="Kristi S." last="Mungovan">Kristi S. Mungovan</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lee, Jeffrey E" sort="Lee, Jeffrey E" uniqKey="Lee J" first="Jeffrey E." last="Lee">Jeffrey E. Lee</name>
</author>
<author>
<name sortKey="Gershenwald, Jeffrey E" sort="Gershenwald, Jeffrey E" uniqKey="Gershenwald J" first="Jeffrey E." last="Gershenwald">Jeffrey E. Gershenwald</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Royal, Richard E" sort="Royal, Richard E" uniqKey="Royal R" first="Richard E." last="Royal">Richard E. Royal</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lucci, Anthony" sort="Lucci, Anthony" uniqKey="Lucci A" first="Anthony" last="Lucci">Anthony Lucci</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M." last="Armer">Jane M. Armer</name>
<affiliation wicri:level="2">
<nlm:aff id="A2">Sinclair School of Nursing/Ellis Fischel Cancer Center, Sinclair School of Nursing, University of Missouri, Columbia, MO</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Sinclair School of Nursing/Ellis Fischel Cancer Center, Sinclair School of Nursing, University of Missouri, Columbia</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N." last="Cormier">Janice N. Cormier</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Melanoma research</title>
<idno type="ISSN">0960-8931</idno>
<idno type="eISSN">1473-5636</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Body Mass Index</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Longitudinal Studies</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (pathology)</term>
<term>Male</term>
<term>Melanoma (complications)</term>
<term>Melanoma (pathology)</term>
<term>Melanoma (surgery)</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Postoperative Complications</term>
<term>Prognosis</term>
<term>Prospective Studies</term>
<term>Sentinel Lymph Node Biopsy</term>
<term>Skin Neoplasms (complications)</term>
<term>Skin Neoplasms (pathology)</term>
<term>Skin Neoplasms (surgery)</term>
<term>Texas (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Complications postopératoires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Indice de masse corporelle</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème (anatomopathologie)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mâle</term>
<term>Mélanome ()</term>
<term>Mélanome (anatomopathologie)</term>
<term>Pronostic</term>
<term>Stade de la tumeur</term>
<term>Texas (épidémiologie)</term>
<term>Tumeurs cutanées ()</term>
<term>Tumeurs cutanées (anatomopathologie)</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Texas</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Lymphoedème</term>
<term>Mélanome</term>
<term>Tumeurs cutanées</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Lymphedema</term>
<term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Lymphoedème</term>
<term>Texas</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Body Mass Index</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Postoperative Complications</term>
<term>Prognosis</term>
<term>Prospective Studies</term>
<term>Sentinel Lymph Node Biopsy</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Complications postopératoires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Indice de masse corporelle</term>
<term>Mâle</term>
<term>Mélanome</term>
<term>Pronostic</term>
<term>Stade de la tumeur</term>
<term>Tumeurs cutanées</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="S1">
<title>Aims</title>
<p id="P1">We sought to prospectively assess limb volume change (LVC) and associated symptoms in patients with melanoma undergoing sentinel lymph node (SLN) biopsy and/or therapeutic lymph node dissection (TLND).</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">Limb volume was measured pre-operatively and post-operatively at 6 and 12 months using a perometer (JUZO 1000M). LVC calculated and used to define 3 groups: <5%, 5-10%, and >10%. A 19-item lymphedema symptom questionnaire was administered at baseline, 6-month and 12-months.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">One hundred eighty-two patients were enrolled. Twelve months after axillary surgery, 9% had LVC 5-10%, and 13% had LVC >10%. Twelve months after inguino-femoral surgery, 10% had LVC 5-10%, and 13% had LVC >10%. There was a significant 7- to 9-fold increase in symptoms for patients with LVC greater than >10% compared to those with LVC <5% (
<italic>P</italic>
<.05). By multivariate analysis, TLND versus SLN biopsy (odds ratio [OR] = 3.18
<italic>P</italic>
<0.01) and borderline significance for lower-versus upper-extremity procedures (OR=1.72;
<italic>P</italic>
=0.07) were associated with LVC >5%.</p>
</sec>
<sec id="S4">
<title>Conclusion</title>
<p id="P4">LVC greater than 5% is common at 12 months following nodal surgery for melanoma and is associated with symptoms. Informed consent for melanoma patients undergoing lymph node surgery should include a discussion of the risks of post-operative lymphedema.</p>
</sec>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Missouri (État)</li>
<li>Texas</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Lee, Jeffrey E" sort="Lee, Jeffrey E" uniqKey="Lee J" first="Jeffrey E." last="Lee">Jeffrey E. Lee</name>
</noCountry>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Hyngstrom, John R" sort="Hyngstrom, John R" uniqKey="Hyngstrom J" first="John R." last="Hyngstrom">John R. Hyngstrom</name>
</region>
<name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M." last="Armer">Jane M. Armer</name>
<name sortKey="Chiang, Yi Ju" sort="Chiang, Yi Ju" uniqKey="Chiang Y" first="Yi-Ju" last="Chiang">Yi-Ju Chiang</name>
<name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N." last="Cormier">Janice N. Cormier</name>
<name sortKey="Cromwell, Kate D" sort="Cromwell, Kate D" uniqKey="Cromwell K" first="Kate D." last="Cromwell">Kate D. Cromwell</name>
<name sortKey="Gershenwald, Jeffrey E" sort="Gershenwald, Jeffrey E" uniqKey="Gershenwald J" first="Jeffrey E." last="Gershenwald">Jeffrey E. Gershenwald</name>
<name sortKey="Lucci, Anthony" sort="Lucci, Anthony" uniqKey="Lucci A" first="Anthony" last="Lucci">Anthony Lucci</name>
<name sortKey="Mungovan, Kristi S" sort="Mungovan, Kristi S" uniqKey="Mungovan K" first="Kristi S." last="Mungovan">Kristi S. Mungovan</name>
<name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I." last="Ross">Merrick I. Ross</name>
<name sortKey="Royal, Richard E" sort="Royal, Richard E" uniqKey="Royal R" first="Richard E." last="Royal">Richard E. Royal</name>
<name sortKey="Xing, Yan" sort="Xing, Yan" uniqKey="Xing Y" first="Yan" last="Xing">Yan Xing</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003258 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003258 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:3881422
   |texte=   Prospective Assessment of Lymphedema Incidence and Lymphedema-associated Symptoms Following Lymph Node Surgery for Melanoma
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23752305" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024